Inficure Bios CEO Sofia Mayans with Gustav Nord, Aptum AB

InfiCure Bio awarded as 2016 Connect Company in Västerbotten

InfiCure Bio was selected as 2016 Connect Company in Västerbotten at Connect Norr annual meeting.Five companies were nominated for the prize and the winner was chosen by the Board of Connect Sweden.

InfiCure Bio was selected as 2016 Connect Company in Västerbotten for its dedicated and enthusiastic work to develop a scalable business model in a high-tech field. InfiCure Bio is targeting chronic inflammatory and fibrotic conditions. Based on a panel of in vivo models for these conditions the company offers effect tests of anti-inflammatory and anti-fibrotic drugs. The unique fibrosis model offered by InfiCure Bio has recently attracted national as well as international attention and last year the start-up company signed a first contract for a full-service preclinical pilot study to test two substances for an american client in Boston. More info on company home page